NGBi Podcasts

Based in Calgary, Alberta, Providence Therapeutics is a Canadian mRNA company focused on personalized cancer vaccines. During the pandemic, Brad Sorenson and his team developed a COVID vaccine that went head to head against Pfizer in clinical trials and held its own, yet almost no one in Canada ever heard about it.

In this episode, host Jim Wilson speaks with founder and CEO Brad Sorenson about a journey that is as personal as it is...

Cerebro Therapeutics is a biotech company based in Quebec City developing disease-modifying treatments for neurodegenerative disorders, with a primary focus on Parkinson's.

Unlike current therapies that only manage symptoms, Cerebro is working to stop the disease from progressing altogether.

In this episode, Jim Wilson speaks with president and co-founder Martin Levesque about a company that spun directly out of his research lab at L...

Based in Fredericton, New Brunswick, ResearchNB is the province's research funding agency. Think of the federal tri-councils CIHR, NSERC, and SSHRC combined into one and operating at a provincial level.

In this episode, Jim Wilson speaks with CEO Candice Pollack about an organization that has moved well beyond the traditional role of a passive funder. Candice explains how ResearchNB now actively connects researchers with industry, g...

Node AI is a software as a medical device company based in Hamilton, Ontario using artificial intelligence to guide surgeons through endobronchial ultrasound, a critical procedure used to determine whether lung cancer has spread to the lymph nodes. Until now, surgeons performing it have essentially been navigating blind.
In this episode, Jim Wilson speaks with co-founder and CEO Mackensey Bacon about a company that grew out of a...

NovaSonix Healthcare is a medtech startup based in London, Ontario developing a portable attachment that converts any standard ultrasound machine into a real-time 3D scanner for musculoskeletal imaging. The goal is to give clinicians MRI-like image quality at the point of care, without the wait.

In Canada, patients with musculoskeletal injuries and diseases currently wait an average of 89 days for a medically necessary MRI.

In this e...

Magellan Biomedical is a medical device company based in Toronto working on a problem that has been hiding in plain sight for almost a century. The fundamental tools used in cardiac catheterization have not meaningfully changed since 1929, and in some of the most critical procedures, conventional tools fail up to twenty percent of the time.

In this episode, Jim Wilson speaks with co-founder and CEO Ali Tavallaei about a device calle...

Dr. Lakshmi Krishnan is Vice President of Research (Life Sciences) at the National Research Council of Canada, one of the country's most influential science organizations in the country. The NRC connects industry, academia, and government to drive innovation and often is quietly behind-the-scenes helping steer some of the most significant advances in Canadian Life Sciences.

In this episode, Jim Wilson speaks with Lakshmi about her j...

Today we reach into the archive to rebroadcast our interview with Maura Campbell, President & CEO of OBIO.

Maura is one of the key leaders in Canada's life sciences community and it was a pleasure to speak with her. Listen in as she shares her thoughts on surviving a severe car accident, some of the obstacles she has faced as a woman working in life sciences, the disappointment of doing everything right but still having a compan...

NerView Surgical is a medtech startup based in Hamilton, Ontario developing a handheld imaging device that gives surgeons the ability to visualize nerves in real time during surgery. It sounds like something that should already exist. It doesn't. The current standard of care is the naked eye.

In this episode, Jim Wilson speaks with founder and CEO Mann Parikh about a company born out of a university course at McMaster, driven forwar...

Vasomune Therapeutics is a clinical stage biotech company that spun out of Sunnybrook Research Institute in Toronto. Their lead molecule targets vascular leak, a common underlying factor in some of the most serious conditions in medicine including sepsis, pneumonia, cerebral edema, and severe burns.

In this episode, Jim Wilson speaks with the President and CEO if Vasomune, Brian Jahns, about a company that has made remarkable p...

Based in Mississauga, Ontario, Kare Chemical Technologies is a synthetic chemistry company working on something that sounds unlikely but could change how we treat chronic pain. By converting a byproduct of citrus orange peels into pharmaceutical grade cannabinoids, the company is developing non-psychoactive alternatives to opioids for patients dealing with long-term pain.

In this episode, host Jim Wilson speaks with co-founder and C...

Claudia Krywiak is President and CEO of the Ontario Centre of Innovation which is a government-funded organization that helps small and medium-sized enterprises commercialize research by connecting industry, academic, and government partners to drive innovation across the province.

In this episode, Jim Wilson speaks with Claudia Krywiak about her journey that began in a small town in Poland, wound through Dubai and Toronto, and even...

In this episode of NGBiLab, Jim Wilson speaks with HygenX.AI co-founder and CTO Kris Rupay about a company that started in a garage during the pandemic and was originally founded to help restore confidence in air travel. What began as a UV disinfection robot for airplane aisles evolved into a potentially life-saving technology now being deployed in hospitals across North America.

The team at HygenX.AI have developed an autonomous AI...

In the next episode of NGBideas Jim Wilson sits down with Gerald Prince who is Senior Director of GMP Manufacturing Gerald Prince at Bluerock Therapeutics.  Gerald's professional journey has wound through some of North America's largest food, consumer goods, and pharmaceutical companies and ultimately landed him at MaRS Discovery District in Toronto.  Gerald's story began in Stockton, California where his childhood home w...

Targa Biomedical is developing pharmacological solutions designed to improve the quality of cells, tissues, and organs for transplantation and regenerative medicine. Based in Montreal, Quebec, their technology has the potential to rescue damaged donor organs that would otherwise be discarded, making more transplants possible for patients in need.

In this episode, host Jim Wilson speaks with co-founder and CEO Shant Der Sarkissian ab...

SPEC Labs is a not-for-profit organization in Mississauga, Ontario that provides shared, ready-to-use wet lab space for life sciences startups in need of room to grow. Their all-inclusive model is designed to remove one of the biggest barriers facing Canadian biotech companies: access to affordable lab infrastructure.

In this episode, host Jim Wilson speaks with founder and CEO Doris Qamar about how a frustrating gap in the Canadian...

Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre in Toronto, Ontario, and a global leader in focused ultrasound technology. His decades of work have helped transform how the medical community approaches treatment for some of the most challenging neurological and oncological conditions.

Join host Jim Wilson as he speaks with Dr. Hynynen about his remarkable journey that began on a...

Cove Neurosciences is a precision neuroscience company in Toronto, Ontario that is focused on translating complex brain data into meaningful insights. Their analytics software helps researchers and pharmaceutical companies better understand human brain function without requiring specialized data science expertise.

In this episode, host Jim Wilson speaks with co-founder and CEO Dr. Nardin Samuel about the company's unexpected beginni...